PCFFS
JAZZ icon

Pacific Center for Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Pacific Center for Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20
Closed -$2.23K – 490
2024
Q3 		$2.23K Hold
20
– – ﹤0.01% 402
2024
Q2 		$2.13K Hold
20
– – ﹤0.01% 401
2024
Q1 		$2.41K Hold
20
– – ﹤0.01% 403
2023
Q4 		$2.46K Hold
20
– – ﹤0.01% 338
2023
Q3 		$2.59K Hold
20
– – ﹤0.01% 353
2023
Q2 		$2.48K Hold
20
– – ﹤0.01% 347
2023
Q1 		$2.93K Buy
+20
New +$2.96K ﹤0.01% 338
2022
Q3 		$3K Hold
20
– – ﹤0.01% 343
2022
Q2 		$3K Hold
20
– – ﹤0.01% 344
2022
Q1 		$3K Hold
20
– – ﹤0.01% 336
2021
Q4 		$3K Hold
20
– – ﹤0.01% 336
2021
Q3 		$3K Hold
20
– – ﹤0.01% 345
2021
Q2 		$4K Hold
20
– – ﹤0.01% 306
2021
Q1 		$3K Hold
20
– – ﹤0.01% 299
2020
Q4 		$3K Buy
+20
New +$2.98K ﹤0.01% 289

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pacific Center for Financial Services's JAZZ Position: Q4 2024 in Review

Pacific Center for Financial Services sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2024, closing a stake of 20 shares — an estimated $2.23K sold.

Pacific Center for Financial Services first reported a position in JAZZ in Q4 2020 and held it in 15 quarters. The position peaked at $4K in Q2 2021. 509 funds tracked by Wall St. Rank hold JAZZ as of Q4 2024.

  • Pacific Center for Financial Services reported no remaining Jazz Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Pacific Center for Financial Services sold 20 Jazz Pharmaceuticals shares in Q4 2024, an estimated $2.23K.
  • Pacific Center for Financial Services first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 15 quarters.
  • Pacific Center for Financial Services's Jazz Pharmaceuticals position peaked at $4K in Q2 2021.
  • 509 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2024.

Based on Pacific Center for Financial Services's 13F filing for Q4 2024, filed 18 Feb 2025.